Search
for
Sort by
Research 151–180 of 1000+
- Under Development JAK Inhibitors for Dermatologic Diseases
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Novedades terapéuticas en tricología
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- What’s new in the treatment of hair loss?
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Modern Management Approaches for Alopecia Areata
- New Treatments for Hair Loss
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Hair Follicle Reconstruction and Stem Cells
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients